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Abstract
Background: Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) is an early characteristic of
multiple organ dysfunction, responsible for high mortality and poor prognosis in patients. The present study aims
to evaluate therapeutic effects and mechanisms of pyrrolidine dithiocarbamate (PDTC) on ALI.
Methods: Alveolar-arterial oxygen difference, lung tissue edema and compromise, NF-B activation in
polymorphonuclear neutrophil (PMN), and systemic levels of tumor necrosis factor-alpha (TNFa) and intercellular
adhesion molecule-1 (ICAM-1) in rabbits induced by the intravenous administration of lipopolysaccharide (LPS) and
treated with PDTC. Production of TNFa and IL-8, activation of Cathepsin G, and PMNs adhesion were also
measured.
Results: The intravenous administration of PDTC had partial therapeutic effects on endotoxemia-induced lung
tissue edema and damage, neutrophil influx to the lung, alveolar-capillary barrier dysfunction, and high systemic
levels of TNFa and ICAM-1 as well as over-activation of NF-B. PDTC could directly and partially inhibit LPS-induced
TNFa hyper-production and over-activities of Cathepsin G. Such inhibitory effects of PDTC were related to the
various stimuli and enhanced through combination with PI3K inhibitor.
Conclusion: NF-B signal pathway could be one of targeting molecules and the combination with other signal
pathway inhibitors may be an alternative of therapeutic strategies for ALI/ARDS.
Keywords: acute lung injury TNF-a?α?, ICAM-1, NF-?κ?B, pyrrolidine dithiocarbamate
Background
Acute lung injury (ALI) and acute respiratory distress
syndrome (ARDS) is an early characteristic of multiple
organ dysfunction, which is responsible for high mortal-
ity and poor prognosis in patients with trauma, infec-
tion, shock, acute pancreatitis or sepsis [1].
Lipopolysaccharide (LPS) as the bacterial pathogen
could trigger the over-production and over-expression
of inflammatory mediators, including cytokines, chemo-
kines, adhesion molecules, reactive oxygen species, and
reactive nitrogen species [2], Primary and/or secondary
excessive production of those mediators could lead to
the development of systemic inflammation and lung tis-
s u ed a m a g ea sw e l la sc o a g u l a tion/anti-coagulation
imbalance, endothelial barrier dysfunction, and multiple
organ dysfunction [3]. ALI could result from the activa-
tion of cytokine networks and the induction of proin-
flammatory gene expression, mediated by activating an
inducible transcription factor, such as nuclear factor-B
(NF-B), a driving force in the initiation and progres-
sion of systemic inflammation, ALI and multiple organ
dysfunction [4,5].
The present study is aimed at evaluating the effects of
pyrrolidine dithiocarbamate (PDTC), an inhibitor of NF-
B, on alveolar-capillary barrier dysfunction, lung tissue
edema and compromise, NF-B activation in polymor-
phonuclear neutrophil (PMN), and systemic levels of
tumor necrosis factor-alpha (TNF-a) and intercellular
adhesion molecule-1 (ICAM-1) in rabbits induced by
the intravenous administration of lipopolysaccharide
(LPS). Furthermore, direct effects of PDTC and dexa-
methasone (DEX) used as reference on PMN activities
characterized by the production of TNF-a and cell
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investigated the potential variation of PDTC effects on
PMNs adhesion after different stimulations with leuko-
triene-B4 (LTB4), interleukin-8 (IL-8), and LPS and
compare the therapeutic effects of the combination of
PDTC and wortmannin.
Materials and methods
Induction of ALI
New Zealand rabbits with a mixture of female and male,
weighing 2.0 kg, were used. The rabbits were kept in a
12:12-h night-day rhythm, fed with standard chow, and
provided water ad libitum. The study was approved by
the Animal Care Committee of The Second Military
University and performed in accordance with the Guide
for the Care and Use of Laboratory Animals. The rab-
bits were anesthetized with intravenous injection of 20%
urethane at the dose of 5 ml/Kg. The femoral vein and
homo-lateral femoral artery were separated, exposed and
cannulated with a heparinized pediatric cardiac catheter
for fluid replacement, drug delivery and blood sampling,
respectively. Endotoxemia-associated ALI was induced
by an intravenous injection of LPS (Escherichia coli,
O111:B4, L-2630, Sigma Chemical, St. Louis, MO) at the
dose of 500 μg/kg. Vehicle or PDTC at the dose of 100
mg/kg PDTC (Sigma) was intravenously administered
one hour after the induction. Ringer’ss o l u t i o nw a s
intravenously infused continuously at the speed of 8 ml/
kg/h during the experiment.
Sampling
Blood was sampled before LPS injection as 0 h, and
then 1, 2, 4 and 6 hours after LPS injection, respectively,
for the measurement of arterial blood gas analysis.
Blood was collected and centrifuged at 3000 × g for 5
min and the serum was stored at -80°C for the measure-
ments of TNF-a and ICAM-1 assay and isolation of
PMNs. The same volume of fluid was replaced in all
animals after sampling. The superior lobe and inferior
part of the right lung was harvested for measurement of
dry/wet (D/W) ratio and pathology, respectively. The
lung tissue was cleansed of blood and weighed as wet
weight, and then kept a 75°C for 72 h for dry weight to
calculate the lung D/W weight ratio.
Pathological score
The lung was perfused through the bronchus at 20 cmH2O
and fixed with 10% formaldehyde solution after the experi-
ment was terminated. The lung tissues were embedded in
paraffin wax, stained with hematoxylin and eosin, and
examined under a light microscope. The lung injury was
scored according to inflammatory changes, hemorrhage of
alveoli and interstitial tissue, and pulmonary edema. Each
pathological change was scored on a scale from 0-3
(normal, 0; minimal change, 1; medium change, 2; and
severe change, 3), as described previously [6].
Alveolar-arterial oxygen difference
PaO2, PaCO2, and pH were measured by blood gas ana-
lyzer (ABL 111, Radiometer, Copenhagen, Denmark).
PaO2 (alveolar oxygen tension) was calculated by the
following equation. PAO2 = (barometric pressure - 47) ×
FiO2 -P a C O 2R. R, an exchange ratio, is assumed as 0.8
as described previously [7]. The alveolar-arterial PO2
difference (PA-aO2) = (barometric pressure - 47) × FiO2
- PaCO2R-P a O 2. The severity of gas exchange impair-
ment (PA-aO2) was examined using the linear correlation
coefficient.
PMN isolation
PMNs were separated as described previously [8].
Briefly, neutrophils were purified under endotoxin-free
conditions. Anti-coagulated blood was added to 6% dex-
tran (mol wt 70,000) in 0.9% sodium chloride solution
in a 3:1 ratio (vol/vol, blood/dextran) and kept at room
temperature for 30 min. The leukocytes were aspirated
and centrifuged at 1000 × g for 6 min and the pellet
was then resuspended in 2 ml RPMI 1640 (GIBCO,
New York) and underlaid with 42% Percoll (Pharmacia,
New Jersey), followed by 51% Percoll, and centrifuged
for 10 minutes at 275 × g. The cells were then washed
twice in RPMI-1640, afterwards the erythrocytes were
lysed. The final cell population was > 98% PMNs by dif-
ferential staining and > 99% viable by trypan blue exclu-
sion. Purified neutrophils were resuspended in RPMI
1640 supplemented at a final concentration of 5 × 10
6
cells/ml and incubated in 48-well cell culture plates at
37°C in a 5% CO2 humidified atmosphere.
Nuclear protein extraction
Nuclear protein was extracted as described previously [4].
Briefly, PMN (5 × 10
6) were lysed in the buffer contain-
ing HEPES (10 mM, pH 7.9), KCl (10 mM), EDTA (0.1
mM), dithiothreitol (1 mM, DTT), and phenylmethylsul-
fonyl fluoride (1 mM, PMSF). Proteins were protected
with 1% protease inhibitor cocktail, containing antipain,
aprotinin and leupeptin (500 μg, respectively), pepstatin
(50 μg), bestatin (750 μg), phosphoramidone (400 μg),
and trypsin inhibitor (500 μg, ROCHE, Mannheim, Ger-
many) in 1 ml. The cell suspension was then centrifuged
at 12000 × g for 5 min (4°C). The nuclear pellet was
resuspended and rocked vigorously for 20 min and total
protein concentration was determined by Bradford assay
(Coomassie Plus, Pierce, Rockford, IL, USA).
Electrophoretic mobility shift assay (EMSA)
Detection of DNA-protein binding by EMSA was done
using LightShift chemiluminescent electrophoretic
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IL, USA). Binding reactions were performed by adding 2
μg of the nuclear extracts to a mixture containing 40
mol of biotin-labeled, double-stranded probes (5’-
AGTTGAGGGGACTTTCCCAGGC-3’)7i n2 0μlo f
binding buffer [10 mM Tris (pH 7.5), 10 mM EDTA,
0.5 mM DTT, 50 mM NaCl, and 5% glycerol] contain-
ing 2 μg of poly(dI-dC):poly(dI-dC). For supershift
experiments, antibody (1 μg) were added to aliquots of
extract and incubated for 20 min on ice before the add-
ing of the reaction mixture. Competition reaction mix-
tures contained a 100-fold molar excess of non-labeled
double-stranded oligoDNAs. The mixtures were then
resolved by PAGE and visualized by horseradish peroxi-
dase-conjugated streptavidin.
Measurements of TNF, ICAM-1 and IL-8
Levels of TNF, ICAM-1 and IL-8 in serum or cell super-
natants were determined using enzyme-linked immuno-
sorbent assay (ELISA) in accordance with the protocol
provided by the manufacturer (LIFEKEY BioMeditech
Co., American). Briefly, primary antibody was plated
and incubated at room temperature overnight. Samples
were added and incubated for 2 h, the plates were
washed, and a biotinylated secondary antibody was
added and incubated for 2 h. Plates were washed again,
and streptavidin bound to horseradish peroxidase was
added for 20 min. After a further wash, tetramethylben-
zidine was added for color development, and the reac-
tion was terminated with 2 M H2SO4. Absorbance was
measured at 450 nm.
Cathepsin G activity
Cathepsin G was isolated and the activity of Cathepsin
G was measured as described previously [9,10]. In brief,
neutrophils were suspended in PBS, sonicated trice and
centrifugated at 600 × g for 10 min. The supernatant
was centrifuged at 16,000 × g for 30 min and the pellet
was resuspended in 1 M NaCl with 0.005% Triton X-
100. Proteins were precipitated by ammonium sulfate
(60% saturation) and then resuspended in 40 ml of 0.05
M Tris-HCl at pH 8.0. After the centrifugation, the
supernatant was subjected to an elastin-Sepharose affi-
nity chromatography column (2.5 × 20 cm) and equili-
brated with 0.05 M Tris buffer at pH 8.0. The part of
cathepsin G was eluted with 1 M NaCl with 0.05 M Na
acetate and 20% DMSO at pH 5.0, pooled and dialyzed
in Vivaspin cut-off columns (5000 MWCO) in 1 M
NaCl with 20 mM Na acetate at pH 5.5. It was then
subjected to ion-exchange chromatography (CM Sepha-
dex C-50) column and washed thrice, and the bound
material was eluted by a linear NaCl gradient from 0.15
to 1 M. 5 ml was collected at a flow rate of 30 ml/h.
Purified enzyme (0.2 μg) was diluted in 200 μlo f
HEPES 0.1 M, NaCl 0.5 M (pH 7.4) and 10% DMSO,
and incubated with N-Suc-Ala-Ala-Pro-Phe-pNA (Suc-
A A P F - p N A ,1m M )a ss u b s t r a t e .T h ea b s o r b a n c ew a s
measured at 410 nm at 25°C.
PMN adhesion
Neutrophils from normal rabbits were isolated, purified
and cultured. Neutrophil adhesion was measured with a
slight modification of the previous demonstration [11].
Cells were labeled with 2’,7 ’-bis(2-carboxyethyl) -5(6)-
carboxyfluorescein acethoxymethyl ester (BCECF/AM,
10 μg/mL; Sigma, MO) for 30 min at 37°C. RPMI-1640
containing 2% fetal calf serum was added for the term-
inal reaction. Human umbilical vein endothelial cells
(HUVECs) and endothelial cell growth medium (EGM-
2, CC3156) were purchased (Clonetics, San Diego, CA),
containing 10% fetal bovine serum, hydrocortisone,
hFGF-B, vEGF, R3-IGF-I, ascorbic acid, hEGF, GA-1000,
and heparin. HUVECs were cultured in 24-well plates
until confluent, at which time different concentrations
of SHBM1009 were added and then incubated for an
additional 12 hours. KC and LTB4 (10 ng/mL) was
added to the wells and incubated for 24 hours and
HUVECs were then co-incubated with 10
6 labeled neu-
trophils/well for 30 minutes at 37°C. After removing
non-adhering cells and washing and lysing adhering
cells, fluorescence was measured with an excitation at
510 nm and emission at 550 nm. The increasing adhe-
sion rate was calculated with the following formulation:
[fluorescence intensity in stimulating cells - fluorescence
intensity in non-stimulating cells]/fluorescence intensity
in stimulating cells X 100.
Experimental design
In order to evaluate the concept of therapeutic effects of
NF-B inhibitor, 60 rabbits were randomly allocated
into three groups (n = 20): 1) animals were challenged
and treated with vehicle (Group A), 2) animals were
challenged with LPS and treated with vehicle (Group B)
and 3) animals were challenged with LPS and treated
with PDTC (Group C). The ALI was defined by measur-
ing lung tissue edema (dry/wet weight ratio), lung
damage (pathology) and dysfunction (PA-aO2). Systemic
inflammatory response was monitored by the serum
levels of TNF, IL-8 and ICAM-1, whereas NF-B invol-
vement was indicated by PMN NF-B activities. In
order to understand the direct effect of PDTC on
PMNs, after the cells reached confluence, PMNs (10
6)
were treated with vehicle, PDTC (100 nM) or dexa-
methesone (DEX) dissolved in dimethyl sulfoxide (final
0.1%) for 4 h in serum-free RPMI medium and chal-
lenged with vehicle or LPS at 1 μg/ml for 24 hours.
Dose-associated effects of PDTC on different stimuli-
induced PMN activation was monitored by measuring
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cle, LPS, IL-8 and leukotriene B4 (LTB4) at 1 μg/ml. In
order to evaluate the potential involvement of phosphoi-
nositide 3-kinase (PI3K) in the activity of PMNs, cells
were treated with vehicle, wortmannin (WT, a specific,
covalent and irreversible inhibitor of the class I, II, and
III PI3K members, 100 nM), PDTC (100 nM), or combi-
nation of WT and PDTC and IL-8 production was
measured.
Statistic analysis
Data were expressed as means ± standard deviations.
T h ed a t af r o mf e m a l ea n dm a l er a b b i t sw e r ep o o l e d
after there was no statistical significance between them.
Groups were compared by Repeated Measures Analysis
of Variance and Kruskal-Wallis test. Least Significant
Difference (LSD) test and the Nemenyi test were used
for comparison between two groups. The statistical ana-
lysis was conducted by SAS 9.1.3 software. P value less
than 0.05 is considered as significant.
Results
No animals died before the termination of experiment.
The values of PA-aO2 in all animals treated with vehicle
or PDTC from 1 hour and onwards after ALI induction
were significantly higher, as compared with those trea-
ted and challenged with vehicle (Figure 1, p < 0.01,
respectively). Values of ALI animals treated with PDTC
were significantly higher than those with vehicle 4 and 6
hours after the administration of LPS (p < 0.05). Patho-
logical alterations of ALI animals treated with vehicle or
PDTC were showed in Figure 1. The lungs of animals
treated with vehicle and challenged with LPS had
thicker alveolar wall, infiltration of leukocytes of which
more than 90% were neutrophils, intra-alveolar hemor-
rhage, formation of micro-thrombosis, alveolar deteleo-
tasis and edematous fluid in alveolar space (Figure 1B).
Pathological alterations in the lungs of animals with LPS
and PDTC were less severe, including clearer alveolar
structure and compromise as well as leukocyte influx
(Figure 1C). There were still definite changes when
compared with animals treated and challenged with
vehicle (Figure 1A).
Values of lung dry/wet weight of animals challenged
with LPS and treated with vehicle or PDTC were signifi-
cantly lower than those challenged and treated with
vehicle (Figure 2A, p < 0.01 or 0.05, respectively). Ani-
mals treated with PDTC had significantly higher levels
of lung dry/wet weight than those with vehicle 24 hours
after the administration of LPS (p < 0.05). Histological
scores of lung pathology in animals challenged with LPS
and treated with vehicle or PDTC were significantly
higher than those without LPS (Figure 2B, p < 0.01,
respectively).
Serum levels of TNFa significantly increased in ani-
mals treated with vehicle or PDTC from 1 hour after
LPS injection, as compared to those challenged with
vehicle (Figure 3A, p < 0.01, respectively). Animals
Figure 1 Values of alveolar-capillary oxygen difference in
animals. Animals were treated and challenged with vehicle (A),
treated with vehicle and challenged with lipopolysaccharide (LPS)
(B), or treated with pyrrolidine dithiocarbamate (PDTC) and
challenged with LPS (C). Animals were intravenously challenged and
treated for 0 (before challenge), 1, 2, 4 and 6 hours and each group
had 20 animals. Histological photographs of the lung (hematoxylin
& eosin, X200) 6 hours after the intravenous challenge and
treatment.
Figure 2 Values of dry/wet lung weight and histological score
in animals. Animals were treated and challenged with vehicle (A),
treated with vehicle and challenged with lipopolysaccharide (LPS)
(B), or treated with pyrrolidine dithiocarbamate (PDTC) and
challenged with LPS (C). Animals were intravenously challenged and
treated for 0 (before challenge), 1, 2, 4 and 6 hours and each group
had 20 animals.
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of TNFa than those with vehicle 4 and 6 hours after
LPS challenge (p < 0.05). Serum levels of ICAM-1 in
animals treated with vehicle were significantly higher
than both those with PDTC 4 and 6 hours after LPS
challenge or those challenged and treated with vehicle
(Figure 3B, p < 0.01, respectively). However, animals
challenged with LPS and treated with vehicle or PDTC
has significantly higher levels of ICAM-1 than those
treated and challenged with vehicle at 1 and 2 hours (p
< 0.05).
Fig 4 demonstrates the ratio of NF-B activity
between the densities of each measurement with the
mean value at 0 hour and representative results of
EMSA analyses of NF-B activation in PMNs (Figure
4A-C). NF-B activity in PMNs from animals treated
with vehicle significantly increased from 1 after LPS
challenge, as compared with those treated with PDTC
or without LPS (p < 0.05 or 0.01, respectively). There
was no statistical difference of NF-B activity between
animals with LPS and PDTC or without LPS, except for
that at post-challenge 4 hours (p < 0.05, Figure 4).
In order to evaluate direct effects of LPS on PMNs,
PMNs were stimulated directly by LPS during cell cul-
ture and activities of PMNs were indicated by produc-
tion of TNFa and cathepsin G. The production of
TNFa from LPS-stimulated cells treated with vehicle,
PDTC or DEX significantly increased with time, as
compared with those without LPS (Figure 5A, p < 0.05
or 0.01, respectively). Levels of TNFa from LPS-stimu-
lated PMNs treated with PDTC or DEX were signifi-
cantly lower than those treated with vehicle (p < 0.05 or
0.01, respectively). There was also significant difference
between LPS-stimulated cells with PDTC or DEX (p <
Figure 3 Serum levels of tumor necrosis factor-alpha (TNF-a)
and intercellular adhesion molecule-1 (ICAM-1) in animals.
Animals were treated and challenged with vehicle (A), treated with
vehicle and challenged with lipopolysaccharide (LPS) (B), or treated
with pyrrolidine dithiocarbamate (PDTC) and challenged with LPS
(C). Animals were intravenously challenged and treated for 0 (before
challenge), 1, 2, 4 and 6 hours and each group had 20 animals.
Figure 4 Activities of nuclear factor kappa B (NF-B) in
polymorphonuclear neutrophils (PMN). Activities were calculated
as referred to the average value of PMN NF-B activities before the
intravenous challenge and treatment. PMNs were isolated from
animals treated and challenged with vehicle (A), treated with
vehicle and challenged with lipopolysaccharide (LPS) (B), or treated
with pyrrolidine dithiocarbamate (PDTC) and challenged with LPS.
Animals were intravenously challenged and treated for 0 (before
challenge), 1, 2, 4 and 6 hours and each group had 20 animals.
Representatives of the electrophoretic mobility shift assay of NF-B
activation in PMN were also shown.
Figure 5 Levels of tumor necrosis factor-alpha (TNF-a)i nt h e
supernatant of cell culture and activities of Cathepsin G of
polymorphonuclear neutrophils (PMN). Cells were treated and
challenged with vehicle (A), treated with dexamethasone (Dx) and
challenged with lipopolysaccharide (LPS) (B), treated with pyrrolidine
dithiocarbamate (PDTC) and challenged with LPS (C), or treated
with vehicle and challenged with LPS (D). The levels of TNF-a were
measured 0, 1, 2, 4, 6, 9 and 12 hours after treatment and
challenge, while activities of Cathepsin G in PMNs were measured
12 hours after treatment and challenge.
Wang et al. Journal of Translational Medicine 2011, 9:61
http://www.translational-medicine.com/content/9/1/61
Page 5 of 90.05 or 0.01, respectively). LPS-stimulated cells had sig-
nificantly higher activity of Cathepsin G than cells with
LPS, while PDTC and DEX significantly reduced LPS-
induced over-activity and DEX showed even better
results than PDTC (p < 0.05, respectively, Figure 5B).
PDTC showed significant inhibitory effects on PMN
adhesion induced by LTB4, IL8 and LPS at different
doses, as shown in Figure 6A. Of them, LTB4-stimulated
cell adhesion was more sensitive to PDTC than IL-8 and
LPS, and IL-8-stimulated adhesion was more sensitive
than LPS did (p < 0.05). Cells treated with WT or
PDTC had significantly lower IL-8 production than
those with vehicle after LPS challenge (Figure 6B, p <
0.05 or 0.01, respectively), even though those produc-
tions were still significantly higher than cells without
LPS challenge (p < 0.01, respectively). The production
of IL-8 from cells treated with the combination of WT
and PDTC was significantly lower than that from cells
with WT or PDTC alone (p < 0.01, respectively).
Discussion
Endotoxemia often happens due to the primary infection
or secondary gut origin sepsis [12-15], leading to the
development of ALI in the early stage of diseases
[16-18]. Multiple intracellular signal pathways, cellular
receptors, inflammatory mediators, cells and systems
have been suggested as contributors to the pathogenesis
of ALI/ARDS. Of them, NF-B was proposed to be the
central and critical factor, regulating the production of
inflammatory mediators [18]. NF-Bi n h i b i t o rc o u l d
attenuate endotoxin-induced ALI [19]. Most of those
investigations were performed in mice and rats, which
have their own advantages and limits, especially for the
evaluation of drug efficacy [2]. The present study was
performed in rabbits and found that PDTC had partial
therapeutic effects on endotoxemia-induced ALI.
Those partial effects of PDTC included were found on
endotoxemia- induced dysfunction of oxygen exchange
between alveolar-capillary barrier, neutrophil influx to
lung tissue, and lung edema and damage. The reason
why our data did not show the fully inhibitory effects of
PDTC on ALI as others found [19,20] may be due to
that PDTC was administered after LPS challenge as the
therapeutic process to mimic the situation in clinic. It is
also possible that PDTC has different effects between
small and large animals, or that the severity of ALI in
our model was more serious. Endotoxins trigger the
production of inflammatory cytokines, responsible for
lung compromise and multiple organ failure [21]. Our
results demonstrated that PDTC could partially inhibit
the production of TNF-a while having more effects on
the production of ICAM-1, even though both may play
critical roles in endotoxin-induced inflammatory
response [22] and were considered as markers of NF-B
activation [19]. However, the previous study demon-
strated that the pretreatment with PDTC did not affect
TNF-a production in bronchoalveolar lavage fluid,
mRNA expression of TNF-a and ICAM-1 in the lung
tissue or NF-B activation in macrophages and neutro-
phil oxidant production [19].
Neutrophils and their production of inflammatory
cytokines, oxygen free radicals, and enzymes together
play the important role in the pathogenesis of ALI. Our
previous studies showed that neutrophils made up more
than 95% of total leukocytes infiltrated into either the
lung tissue or alveolar space in mice with LPS-induced
ALI [23]. In the present study, we also noticed that the
neutrophil influx into the lung tissue increased in rab-
bits with endotoxemia-induced ALI, while being partially
inhibited by PDTC. However, other studies demon-
strated that PDTC prevented primary or secondary ALI
induced by LPS or mesenteric ischemia/reperfusion
probably due to the inhibitory effects on lung lipid per-
oxidation, malondialdehyde, glutathione, and nitric
oxide, rather than the reduction of pulmonary neutro-
phil sequestration and oxidant production [19,24]. Our
study showed evidence that PDTC could directly inhibit
the activation of PMNs characterized by the production
of TNF-a and the activity of Cathepsin G.
Inhibitory effects of PDTC were dependent upon the
stimuli, supported by the fact that LPS-stimulated cell
adhesion had less sensitive to PDTC than LTB4 and IL-
8. LTB4 induced a rapid but transient adhesion of PMN
to an albumin-coated plastic surface and to cultured
human umbilical vein endothelial cells associated with
Figure 6 The adhesion of polymorphonuclear neutrophils
(PMN). The adhesion was measured 24 hours after treatment with
pyrrolidine dithiocarbamate (PDTC) at different concentrations and
challenges with leukotriene B4 (LTB4), interleukin-8 (IL-8) and
lipopolysaccharide (LPS). Levels of IL-8 in the supernatant of PMN
culture were measured 0, 3, 6, 9, 12, 18 and 24 hours after the
challenge with LPS or vehicle and treatment with vehicle, PDTC
alone, wortmannin (WT) alone or the combination of PDTC and WT.
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most chemoattractant factors causing PMN adhesion
and migration, probably through the phosphorylation
and translocation of cytosolic gIVaPLA2 to the nucleus,
change in cell shape, polymerization of F-actin, tyrosine
phosphorylation as well as enzymatic activity of proline-
rich tyrosine kinase 2, a non-receptor protein tyrosine
kinase [26,27]. The PMN response to LPS was less sen-
sitive in the absence of serum, since LPS stimulated
neutrophils by interacting with specific cellular recep-
tors, although upregulationo fC D 1 1 b / C D 1 8c o u l ds t i l l
be seen using higher concentrations of LPS [28]. Our
data also indicate that LPL-stimulated response had less
sensitivity to PDTC which may contribute to the partial
inhibitory effects of PDCT.
Activities of NF-B were increased and associated with
the levels of inflammatory mediators in BAL fluid from
patients with ARDS [29,30]. In addition, NF-B activa-
tion has been identified in alveolar macrophages from
humans with ARDS [31]. Endotoxins can activate NF-B
and then initiate transcription and interpretation of many
cytokine genes [32,33] closely related with inflammation
and immune reaction. NF-B plays a critical role in the
transcriptional activation of multiple genes that contribu-
ted to the development of ALI [34]. The present study
showed that NF-B activity in PMNs increased, accom-
panied with elevated levels of TNF-a and ICAM-1 in the
e a r l ys t a g eo fA L I ,w h i l eP D T Cc o u l dr e d u c eL P S -
induced over-activation of NF-B. Although it should be
stated that PDTC has been considered as the NF-B inhi-
bitor, but it also has another multitude of effects, e.g.
antioxidant [19,35]. For example, the protective effects of
PDTC on LPS-induced ALI was proposed to be asso-
ciated with antioxidant rather than NF-B activity, since
pre-treatment with PDTC failed to reduce on LPS-
induced NF-B DNA binding activity in macrophage
nuclear extracts [19]. The present study showed the ther-
apeutic effects of PDTC on over-activation of NF-Bi n
neutrophils. However, the down-regulated activities of
NF-B did not show a clear correlation and consistency
with the therapeutic effects of PDTC on systemic levels
of TNF-a, lung tissue edema and damage, and lung dys-
function induced by LPS.
It was hypothesized that PDTC may interfere with
NF-B DNA binding activity through phorbol ester 12-
O-tetradecanoylphorbol-13-acetate (TPA) or TNF-a-sti-
mulated signaling pathway. PDTC did not inhibit TNF-
a-induced NF-kappaB DNA binding activity but poten-
tiated the effect of TNF-a on kappaB-dependent gene
expression. PDTC could induce AP-1 DNA binding and
AP-1 reporter gene activity, leading to the inhibition of
NF-B activity [36]. TPA-induced signaling pathway
includes the activation of extracellular signal-regulated
kinase 1/2, p38 mitogen-activated protein kinase
(MAPK), and PI3K/Akt, which are upstream of NFB.
Our data showed that the combination of PDTC with
PI3K inhibitor Wortmannin had more inhibitory effects
on LPS-induced PMN overproduction of IL-8, than
either on its own. Wortmannin is a specific, covalent
inhibitor of PI3Ks, for the class I, II, and III PI3K mem-
bers, although it can also inhibit other PI3K-related
enzymes such as mTOR, DNA-PK, some PI4Ks, myosin
light chain kinase, members of the polo-like kinase
family and MAPK [37,38]. It indicates that multiple sig-
naling pathways associated PI3K-NF-B communication
may be involved in the hyper-activation of PMNs and
endotoxemia-induced ALI. This was also supported by
the finding that inhibitory effects of DEX on LPS-
induced TNF-a production and Cathepsin G over-acti-
vation were significantly better than PDTC. It seems
that the inhibitory effects of PDTC were not only
dependent upon the variation of stimuli and severities of
the disease, but also different between targeting cells.
For example, effects of PDTC on macrophages might be
related with the antioxidant process rather than TNF-a
and NF-B [19], but not on the epithelial cells [39].
However, this is the preliminary study to evaluate PDTC
effects in large animals, so it would be important to
show the dose-dependent efficacy of PDTC and addi-
tional target-specific inhibitors, even though it may be
difficult to be found for rabbits. It is also more helpful if
the study could measure the recruitment of leukocytes
from the circulation to the interstitial tissue and alveolar
space. The use together with blocking a PI3K imply
potential effect in a multimodal therapeutic setting,
which should be further explored due to the complexity
of mechanisms involved in ALI.
Conclusion
The present study demonstrated that the intravenous
administration of PDTC had partial therapeutic effects
on endotoxemia-induced lung tissue edema and damage,
neutrophil influx to the lung, alveolar-capillary barrier
dysfunction, and high systemic levels of TNF-a and
ICAM-1 as well as over-activation of NF-B. PDTC
could directly and partially inhibit LPS-induced TNF-a
hyper-production and over-activities of Cathepsin G.
Such inhibitory effects of PDTC were related to the var-
ious stimuli and enhanced through combination with
PI3K inhibitor. Thus, our data indicate that NF-Bs i g -
nal pathway may be one of the molecules to target and
the combination with other signal pathway inhibitors
may be an alternative of therapeutic strategies for ALI/
ARDS.
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